Profile
Sector:
HealthcareCountry:
United StatesIPO:
07 May 2015Website:
http://www.collegiumpharma.comNext earnings report:
02 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Tue, 02 Jul 2024 21:48:46 GMTDividend
Analysts recommendations
Institutional Ownership
COLL Latest News
Collegium Pharmaceutical (COLL) lacks the necessary elements for a potential earnings beat in its upcoming report. Be ready with the key expectations.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Collegium Pharmaceutical (COLL) could produce exceptional returns because of its solid growth attributes.
Does Collegium Pharmaceutical (COLL) have what it takes to be a top stock pick for momentum investors? Let's find out.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
UGP, HMC and COLL made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 29, 2023.
Collegium Pharmaceutical's (COLL) Q4 2023 Earnings Call Transcript
The headline numbers for Collegium Pharmaceutical (COLL) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Collegium Pharmaceutical (COLL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Collegium Pharmaceutical (COLL) has seen solid earnings estimate revision activity over the past two months, and belongs to a strong industry as well.
What type of business is Collegium Pharmaceutical?
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
What sector is Collegium Pharmaceutical in?
Collegium Pharmaceutical is in the Healthcare sector
What industry is Collegium Pharmaceutical in?
Collegium Pharmaceutical is in the Drug Manufacturers - Specialty & Generic industry
What country is Collegium Pharmaceutical from?
Collegium Pharmaceutical is headquartered in United States
When did Collegium Pharmaceutical go public?
Collegium Pharmaceutical initial public offering (IPO) was on 07 May 2015
What is Collegium Pharmaceutical website?
https://www.collegiumpharma.com
Is Collegium Pharmaceutical in the S&P 500?
No, Collegium Pharmaceutical is not included in the S&P 500 index
Is Collegium Pharmaceutical in the NASDAQ 100?
No, Collegium Pharmaceutical is not included in the NASDAQ 100 index
Is Collegium Pharmaceutical in the Dow Jones?
No, Collegium Pharmaceutical is not included in the Dow Jones index
When does Collegium Pharmaceutical report earnings?
The next expected earnings date for Collegium Pharmaceutical is 02 August 2024